Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2025 06:00 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas

Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas
June 18, 2024 10:17 ET | Source: Research and Markets

Comprehensive Insights of Global Cyclin-Dependent Kinase Inhibitor Pipeline

Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The detailed report furnishes...
June 13, 2024 06:00 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Announces Collaboration with Novo Nordisk in Diabetes

Biosplice enters into a pre-clinical collaboration with Novo Nordisk to develop inhibitors of DYRK for diabetes
April 26, 2024 09:34 ET | Source: Research and Markets

Checkpoint Kinase Inhibitors Pipeline Insight Report, 2024: Analysis of 15+ Companies and 15+ Pipeline Drugs which are Poised to Transform Cancer Therapeutics

Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Checkpoint Kinase Inhibitors - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. As the global healthcare...
April 18, 2024 06:00 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results

Presentation of OA-07 Phase 3 Long-Term Results for Lorecivivint and Preliminary Analysis of OA-21 Trial 12-Week Pain Results
March 08, 2024 13:36 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program

Biosplice announced today that its collaboration with The Roskamp Institute has been awarded funding by the US Department of Defense.
March 30, 2023 02:46 ET | Source: Growth Plus Reports

Kinase Inhibitors Market Growth Accelerated by The Increased Prevalence of Cancer, Projected to Reach US$ 93.0 Billion by 2031: Growth Plus Reports Study

Newark, New Castle, USA, March 30, 2023 (GLOBE NEWSWIRE) -- The global kinase inhibitors market is expected to reach US$ 93.0 billion by 2031, with a revenue CAGR of 6.20%, according to a new Growth...
March 15, 2023 09:30 ET | Source: SPHERICAL INSIGHTS LLP

Global Kinase Inhibitors Market Size To Grow USD 95.3 Billion By 2030 | CAGR of 7.3%

New York, United States , March 15, 2023 (GLOBE NEWSWIRE) -- The Global Kinase Inhibitors Market Size to grow from USD 57.2 Billion in 2021 to USD 95.3 Billion by 2030, at a Compound Annual Growth...
March 23, 2022 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present at the Next Generation Kinase Inhibitors Summit

NEWTOWN, Pa., March 23, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
May 06, 2021 20:15 ET | Source: DelveInsight Business Research LLP

Checkpoint Kinase Inhibitor Pipeline Analysis: Key Pharma Companies, and Emerging Therapies Offering New Horizons in Cancer Care

Los Angeles, USA, May 06, 2021 (GLOBE NEWSWIRE) -- Checkpoint Kinase Inhibitor Pipeline Analysis: Key Pharma Companies, and Emerging Therapies Offering New Horizons in Cancer Care Several...